A 0 1 0 1 O
negative 2 10 2 10 B-pregnancy
pregnancy 11 20 11 20 I-pregnancy
test 21 25 21 25 O
will 26 30 26 30 O
be 31 33 31 33 O
required 34 42 34 42 O
for 43 46 43 46 O
all 47 50 47 50 O
female 51 57 51 57 B-gender
subjects 58 66 58 66 I-gender
with 67 71 67 71 O
child 72 77 72 77 O
bearing 78 85 78 85 O
potential 86 95 86 95 O

Age 0 3 96 99 B-age
≥ 4 5 100 101 O
6 6 7 102 103 B-lower_bound
months 8 14 104 110 I-lower_bound

Any 0 3 111 114 O
additional 4 14 115 125 O
medical 15 22 126 133 B-chronic_disease
condition 23 32 134 143 I-chronic_disease
, 32 33 143 144 O
serious 34 41 145 152 O
intercurrent 42 54 153 165 B-chronic_disease
illness 55 62 166 173 I-chronic_disease
, 62 63 173 174 O
or 64 66 175 177 O
other 67 72 178 183 O
extenuating 73 84 184 195 O
circumstance 85 97 196 208 O
that 98 102 209 213 O
, 102 103 213 214 O
in 104 106 215 217 O
the 107 110 218 221 O
opinion 111 118 222 229 O
of 119 121 230 232 O
the 122 125 233 236 O
investigator 126 138 237 249 O
, 138 139 249 250 O
may 140 143 251 254 O
significantly 144 157 255 268 O
interfere 158 167 269 278 O
with 168 172 279 283 O
study 173 178 284 289 O
compliance 179 189 290 300 O

Female 0 6 301 307 B-gender
must 7 11 308 312 O
also 12 16 313 317 O
be 17 19 318 320 O
non 20 23 321 324 O
- 23 24 324 325 O
lactating 24 33 325 334 O

Histologically 0 14 335 349 O
diagnosed 15 24 350 359 O
neuroendocrine 25 39 360 374 B-cancer
tumor 40 45 375 380 I-cancer
or 46 48 381 383 O
other 49 54 384 389 O
tumor 55 60 390 395 O
with 61 65 396 400 O
probable 66 74 401 409 O
somatostatin 75 87 410 422 O
receptors 88 97 423 432 O
subtype 98 105 433 440 O
2 106 107 441 442 O

If 0 2 443 445 O
a 3 4 446 447 O
false 5 10 448 453 O
pregnancy 11 20 454 463 B-pregnancy
test 21 25 464 468 O
is 26 28 469 471 O
suspected 29 38 472 481 O
, 38 39 481 482 O
e.g. 40 44 483 487 O
, 44 45 487 488 O
perimenopausal 46 60 489 503 O
condition 61 70 504 513 O
, 70 71 513 514 O
an 72 74 515 517 O
obstetrician 75 87 518 530 O
will 88 92 531 535 O
be 93 95 536 538 O
consulted 96 105 539 548 O
to 106 108 549 551 O
determine 109 118 552 561 O
if 119 121 562 564 O
she 122 125 565 568 O
is 126 128 569 571 O
/ 128 129 571 572 O
is 129 131 572 574 O
not 132 135 575 578 O
capable 136 143 579 586 O
of 144 146 587 589 O
becoming 147 155 590 598 B-pregnancy
pregnant 156 164 599 607 I-pregnancy

Inability 0 9 608 617 O
to 10 12 618 620 O
complete 13 21 621 629 O
the 22 25 630 633 O
needed 26 32 634 640 O
investigational 33 48 641 656 O
and 49 52 657 660 O
standard 53 61 661 669 O
- 61 62 669 670 O
of 62 64 670 672 O
- 64 65 672 673 O
care 65 69 673 677 O
imaging 70 77 678 685 O
examinations 78 90 686 698 O
due 91 94 699 702 O
to 95 97 703 705 O
other 98 103 706 711 O
reasons 104 111 712 719 O
( 112 113 720 721 O
severe 113 119 721 727 O
claustrophobia 120 134 728 742 B-chronic_disease
, 134 135 742 743 O
radiation 136 145 744 753 B-chronic_disease
phobia 146 152 754 760 I-chronic_disease
, 152 153 760 761 O
etc 154 157 762 765 O
. 157 158 765 766 O
) 158 159 766 767 O

Inability 0 9 768 777 O
to 10 12 778 780 O
lie 13 16 781 784 O
still 17 22 785 790 O
for 23 26 791 794 O
the 27 30 795 798 O
entire 31 37 799 805 O
imaging 38 45 806 813 O
time 46 50 814 818 O
( 51 52 819 820 O
due 52 55 820 823 O
to 56 58 824 826 O
cough 59 64 827 832 O
, 64 65 832 833 O
severe 66 72 834 840 O
arthritis 73 82 841 850 B-chronic_disease
, 82 83 850 851 O
etc 84 87 852 855 O
. 87 88 855 856 O
) 88 89 856 857 O

Karnofsky 0 9 858 867 B-clinical_variable
performance 10 21 868 879 I-clinical_variable
status 22 28 880 886 I-clinical_variable
or 29 31 887 889 O
Lansky 32 38 890 896 B-clinical_variable
Play 39 43 897 901 I-clinical_variable
Scale 44 49 902 907 I-clinical_variable
status 50 56 908 914 I-clinical_variable
of 57 59 915 917 O
≥ 60 61 918 919 O
60 62 64 920 922 B-lower_bound
( 65 66 923 924 O
or 66 68 924 926 O
ECOG 69 73 927 931 O
/ 73 74 931 932 O
WHO 74 77 932 935 O
equivalent 78 88 936 946 O
) 88 89 946 947 O

Lanreotide 0 10 948 958 B-treatment
injection 11 20 959 968 I-treatment
within 21 27 969 975 O
8 28 29 976 977 B-upper_bound
weeks 30 35 978 983 I-upper_bound
of 36 38 984 986 O
Ga-68 39 44 987 992 B-treatment
DOTATOC 45 52 993 1000 I-treatment
PET 53 56 1001 1004 I-treatment
/ 56 57 1004 1005 I-treatment
CT 57 59 1005 1007 I-treatment
( 60 61 1008 1009 O
+ 61 62 1009 1010 O
/-5 62 65 1010 1013 O
% 65 66 1013 1014 O
) 66 67 1014 1015 O

Peptide 0 7 1016 1023 B-treatment
receptor 8 16 1024 1032 I-treatment
radionuclide 17 29 1033 1045 I-treatment
therapy 30 37 1046 1053 I-treatment
( 38 39 1054 1055 I-treatment
PRRT 39 43 1055 1059 I-treatment
) 43 44 1059 1060 I-treatment
within 45 51 1061 1067 O
4 52 53 1068 1069 B-upper_bound
weeks 54 59 1070 1075 I-upper_bound
of 60 62 1076 1078 O
Ga-68 63 68 1079 1084 O
DOTATOC 69 76 1085 1092 O
PET 77 80 1093 1096 B-treatment
/ 80 81 1096 1097 O
CT 81 83 1097 1099 B-treatment
scan 84 88 1100 1104 I-treatment

SQ 0 2 1105 1107 B-clinical_variable
Octreotide 3 13 1108 1118 I-clinical_variable
within 14 20 1119 1125 O
12 21 23 1126 1128 B-upper_bound
hours 24 29 1129 1134 I-upper_bound

Subject 0 7 1135 1142 O
is 8 10 1143 1145 O
male 11 15 1146 1150 B-gender

Subject 0 7 1151 1158 O
weighs 8 14 1159 1165 B-clinical_variable
more 15 19 1166 1170 O
than 20 24 1171 1175 O
450 25 28 1176 1179 B-lower_bound
pounds 29 35 1180 1186 I-lower_bound

Subjects 0 8 1187 1195 O
who 9 12 1196 1199 O
weigh 13 18 1200 1205 B-clinical_variable
more 19 23 1206 1210 O
than 24 28 1211 1215 O
450 29 32 1216 1219 B-lower_bound
pounds 33 39 1220 1226 I-lower_bound
will 40 44 1227 1231 O
not 45 48 1232 1235 O
be 49 51 1236 1238 O
able 52 56 1239 1243 O
to 57 59 1244 1246 O
fit 60 63 1247 1250 O
inside 64 70 1251 1257 O
the 71 74 1258 1261 O
imaging 75 82 1262 1269 O
machines 83 91 1270 1278 O

Treatment 0 9 1279 1288 B-treatment
with 10 14 1289 1293 I-treatment
Sandostatin 15 26 1294 1305 I-treatment
LAR 27 30 1306 1309 I-treatment
within 31 37 1310 1316 O
4 38 39 1317 1318 B-upper_bound
weeks 40 45 1319 1324 I-upper_bound

female 0 6 1325 1331 B-gender
who 7 10 1332 1335 O
is 11 13 1336 1338 O
either 14 20 1339 1345 O
surgically 21 31 1346 1356 O
sterile 32 39 1357 1364 O
( 40 41 1365 1366 O
has 41 44 1366 1369 O
had 45 48 1370 1373 O
a 49 50 1374 1375 O
documented 51 61 1376 1386 O
bilateral 62 71 1387 1396 O
oophorectomy 72 84 1397 1409 B-treatment
and/or 85 91 1410 1416 O
documented 92 102 1417 1427 O
hysterectomy 103 115 1428 1440 B-treatment
) 115 116 1440 1441 O

postmenopausal 0 14 1442 1456 O
( 15 16 1457 1458 O
> 16 17 1458 1459 O
1 18 19 1460 1461 B-lower_bound
years 20 25 1462 1467 I-lower_bound
without 26 33 1468 1475 O
menses 34 40 1476 1482 O
) 40 41 1482 1483 O

≥60 0 3 1484 1487 O
years 4 9 1488 1493 I-lower_bound
old 10 13 1494 1497 O
, 13 14 1497 1498 O
or 14 16 1498 1500 O
of 17 19 1501 1503 O
childbearing 20 32 1504 1516 O
potential 33 42 1517 1526 O
for 43 46 1527 1530 O
whom 47 51 1531 1535 O
a 52 53 1536 1537 O
pregnancy 54 63 1538 1547 B-pregnancy
test 64 68 1548 1552 O
( 69 70 1553 1554 O
with 70 74 1554 1558 O
the 75 78 1559 1562 O
results 79 86 1563 1570 O
known 87 92 1571 1576 O
prior 93 98 1577 1582 O
to 99 101 1583 1585 O
investigational 102 117 1586 1601 B-treatment
product 118 125 1602 1609 I-treatment
administration 126 140 1610 1624 O
) 140 141 1624 1625 O
is 142 144 1626 1628 O
negative 145 153 1629 1637 O

